FDA Approved: BACLOFEN — Supplemental Application (Wilshire Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves a supplemental application for baclofen from Wilshire Pharmaceuticals, Inc., updating the existing baclofen product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Spinal Cord Injury

Drugs mentioned

• BACLOFEN (Baclofen)

Snippet

SUPPL AP for BACLOFEN (BACLOFEN)